News

In a recent study, scientists not only show how cancer hijacks this tightly regulated splicing and rearranging of RNA but also introduce a potential therapeutic strategy that could slow or even shrink aggressive and hard-to-treat tumors.

Researchers from the VIB-KU Leuven Center for Cancer Biology, in collaboration with other scientists, have discovered a way to enhance the immune system's ability to fight cancer by reprogramming T-cell metabolism.

Researchers at the Garvan Institute of Medical Research have uncovered how pancreatic cancer hijacks a crucial metabolism ‘switch’ to help it spread, revealing a potential new treatment strategy for this highly aggressive disease.

Avapritinib, an FDA-approved drug used to treat other types of cancer, also decreases aggressive gliomas in animal models and in an initial cohort of patients with high-grade glioma.

Researchers from Mayo Clinic have identified specific proteins — fibronectin and smooth muscle actin — within colorectal cancer tissues that are associated with resistance to immunotherapy treatment.

A new study, led by researchers at Arizona State University, explores the relationship between diet, blood sugar (specifically glucose) and cancer prevalence across a broad range of vertebrate species.

Pancreatic cancer has a notorious capacity to adapt and resist therapy. Now, a study uncovers a hidden driver of this adaptability: extrachromosomal DNA (ecDNA).

Researchers have uncovered critical mechanisms linked to metabolic insufficiencies that underlie plasmacytoid dendritic cell suppression after infection.

A new study explored associations between the reported number of sunburns and sociodemographic characteristics, in addition to examining the prevalence of protective skin behaviors adopted by the US adult population.

A study of over 500,000 individuals links maternal smoking to genetic changes that impact offspring’s long-term health. Male children face higher risks, including early mortality and cancer, while women are more prone to reproductive issues.